ロード中...
MET and VEGF: synergistic targets in castration-resistant prostate cancer
Recent advances in the treatment of prostate cancer have resulted in improved outcomes, including longer survival, but new options are needed for treating patients with castration-resistant disease, particularly in the presence of bone metastasis. Data from preclinical models and clinical biomarker...
保存先:
| 出版年: | Clin Transl Oncol |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4422050/ https://ncbi.nlm.nih.gov/pubmed/21975330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-011-0719-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|